155 related articles for article (PubMed ID: 24354449)
1. Wild-type K-ras has a tumour suppressor effect on carcinogen-induced murine colorectal adenoma formation.
Luo F; Poulogiannis G; Ye H; Hamoudi R; Dong G; Zhang W; Ibrahim AE; Arends MJ
Int J Exp Pathol; 2014 Feb; 95(1):8-15. PubMed ID: 24354449
[TBL] [Abstract][Full Text] [Related]
2. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
[TBL] [Abstract][Full Text] [Related]
3. Mutant K-ras promotes carcinogen-induced murine colorectal tumourigenesis, but does not alter tumour chromosome stability.
Luo F; Poulogiannis G; Ye H; Hamoudi R; Zhang W; Dong G; Arends MJ
J Pathol; 2011 Feb; 223(3):390-9. PubMed ID: 21171084
[TBL] [Abstract][Full Text] [Related]
4. The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.
Patek CE; Arends MJ; Rose L; Luo F; Walker M; Devenney PS; Berry RL; Lawrence NJ; Ridgway RA; Sansom OJ; Hooper ML
BMC Gastroenterol; 2008 Jun; 8():24. PubMed ID: 18554389
[TBL] [Abstract][Full Text] [Related]
5. Mutated K-ras(Asp12) promotes tumourigenesis in Apc(Min) mice more in the large than the small intestines, with synergistic effects between K-ras and Wnt pathways.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Int J Exp Pathol; 2009 Oct; 90(5):558-74. PubMed ID: 19765110
[TBL] [Abstract][Full Text] [Related]
6. Ki-ras and the characteristics of mouse lung tumors.
Ramakrishna G; Bialkowska A; Perella C; Birely L; Fornwald LW; Diwan BA; Shiao YH; Anderson LM
Mol Carcinog; 2000 Jul; 28(3):156-67. PubMed ID: 10942532
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features.
Harada K; Hiraoka S; Kato J; Horii J; Fujita H; Sakaguchi K; Shiratori Y
Br J Cancer; 2007 Nov; 97(10):1425-31. PubMed ID: 17923875
[TBL] [Abstract][Full Text] [Related]
8. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
[TBL] [Abstract][Full Text] [Related]
9. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
10. Mutationally activated K-ras 4A and 4B both mediate lung carcinogenesis.
Patek CE; Arends MJ; Wallace WA; Luo F; Hagan S; Brownstein DG; Rose L; Devenney PS; Walker M; Plowman SJ; Berry RL; Kolch W; Sansom OJ; Harrison DJ; Hooper ML
Exp Cell Res; 2008 Mar; 314(5):1105-14. PubMed ID: 18062963
[TBL] [Abstract][Full Text] [Related]
11. K-RAS-2 gene mutations as predictors of metachronous colorectal adenomas.
Nusko G; Sachse R; Mansmann U; Wittekind C; Hahn EG
Scand J Gastroenterol; 1997 Oct; 32(10):1035-41. PubMed ID: 9361177
[TBL] [Abstract][Full Text] [Related]
12. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas.
Nuzum EO; Malkinson AM; Beer DG
Mol Carcinog; 1990; 3(5):287-95. PubMed ID: 2244961
[TBL] [Abstract][Full Text] [Related]
13. Impact of Cellular Genetic Make-up on Colorectal Cancer Cell Lines Response to Ellagic Acid: Implications of Small Interfering RNA.
Yousef AI; El-Masry OS; Abdel Mohsen MA
Asian Pac J Cancer Prev; 2016; 17(2):743-8. PubMed ID: 26925673
[TBL] [Abstract][Full Text] [Related]
14. Conditional expression of mutated K-ras accelerates intestinal tumorigenesis in Msh2-deficient mice.
Luo F; Brooks DG; Ye H; Hamoudi R; Poulogiannis G; Patek CE; Winton DJ; Arends MJ
Oncogene; 2007 Jun; 26(30):4415-27. PubMed ID: 17297472
[TBL] [Abstract][Full Text] [Related]
15. The Ras effector RASSF2 is a novel tumor-suppressor gene in human colorectal cancer.
Akino K; Toyota M; Suzuki H; Mita H; Sasaki Y; Ohe-Toyota M; Issa JP; Hinoda Y; Imai K; Tokino T
Gastroenterology; 2005 Jul; 129(1):156-69. PubMed ID: 16012945
[TBL] [Abstract][Full Text] [Related]
16. Does Mutated
Rice PFS; Ehrichs KG; Jones MS; Chen H; Hsu CH; Abril ER; Nagle RB; Besselsen DG; Barton JK; Ignatenko NA
Cancer Prev Res (Phila); 2018 Jan; 11(1):16-26. PubMed ID: 29118162
[TBL] [Abstract][Full Text] [Related]
17. MLH1-deficient Colorectal Carcinoma With Wild-type BRAF and MLH1 Promoter Hypermethylation Harbor KRAS Mutations and Arise From Conventional Adenomas.
Farchoukh L; Kuan SF; Dudley B; Brand R; Nikiforova M; Pai RK
Am J Surg Pathol; 2016 Oct; 40(10):1390-9. PubMed ID: 27438990
[TBL] [Abstract][Full Text] [Related]
18. PHLPP is a negative regulator of RAF1, which reduces colorectal cancer cell motility and prevents tumor progression in mice.
Li X; Stevens PD; Liu J; Yang H; Wang W; Wang C; Zeng Z; Schmidt MD; Yang M; Lee EY; Gao T
Gastroenterology; 2014 May; 146(5):1301-12.e1-10. PubMed ID: 24530606
[TBL] [Abstract][Full Text] [Related]
19. Molecular mechanisms underlying the tumorigenesis of colorectal adenomas: correlation to activated K-ras oncogene.
Wang JY; Wang YH; Jao SW; Lu CY; Kuo CH; Hu HM; Hsieh JS; Chong IW; Cheng TL; Lin SR
Oncol Rep; 2006 Dec; 16(6):1245-52. PubMed ID: 17089045
[TBL] [Abstract][Full Text] [Related]
20. Genetic epidemiology of mutated K-ras proto-oncogene, altered suppressor genes, and microsatellite instability in colorectal adenomas.
Rashid A; Zahurak M; Goodman SN; Hamilton SR
Gut; 1999 Jun; 44(6):826-33. PubMed ID: 10323885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
